Current Health to invest in coordinating in-home staffing, services. Read the announcement.

Advanced Therapies for Community Clinics

Scale Advanced Therapy Delivery Closer to Patients

Don’t lose your patients to distant academic medical centers. With Current Health, community practices can deliver CAR-T and bispecifics locally—with turnkey infrastructure, minimal staffing and upfront investment needs, FACT accreditation support, and economics that work.

80% of the Advanced Therapy Opportunity is in Community Settings

Today, patients travel hundreds of miles to academic medical centers for CAR-T and bispecific therapies, but they don’t have to. With the right infrastructure, community practices can deliver these life-saving treatments closer to home—capturing revenue, improving patient experience, and expanding access.

Keep Patients Local

Stop losing patients to distant AMCs. Deliver advanced therapies in your community, maintaining continuity of care and the patient relationships you’ve built.

Capture High-Value Revenue

Community clinics can capture high-value episodes spanning infusion, monitoring, and follow-up services, while delivering care at a lower total cost than academic centers.

Compete on Experience

Patients prefer receiving care close to home, surrounded by family. Community delivery offers a better experience than weeks away at a distant medical center.

Starting a Cell Therapy Program is Complex.
We Make it Easier.

Academic medical centers have spent years and millions building cell therapy infrastructure. Community practices don’t have that runway. We provide the complete operational and clinical infrastructure to launch quickly and safely.

Everything You Need to Launch and Scale Advanced Therapy Delivery

Our turnkey solution gives community practices the infrastructure to deliver cell therapies without the capital investment and operational complexity of building it yourself.

FACT Accreditation Support

Guidance through the entire FACT accreditation process, including policy development, staff training, and readiness assessments.

Manufacturer Support

We have extensive partnerships with manufacturers to ensure you can contract and certify with manufacturers in a streamlined way.

Apheresis and Infusion Partnerships

Established relationships with mobile apheresis providers, blood banks and infusion providers to enable collection & infusion without capital investment.

Payer Strategy

Support for commercial payer contracting, including episode-based payment models and prior authorization workflows.

24/7 Clinical Command Center

Our Clinical Command Center provides around-the-clock monitoring by RNs trained in CRS and ICANS management, licensed in all 50 states.

Early CRS Detection

FDA-cleared continuous monitoring devices and advanced algorithms detect CRS 7 hours earlier than standard of care, allowing early treatment and controlled escalation.

Virtual ICANS Assessments

Remote neurotoxicity assessments with ICE scoring, enabling early detection without 24/7 on-site neurology coverage.

Outcomes Measurement and Improvement

Comprehensive analytics and reporting to demonstrate program quality to payers, pharma partners, and referral sources.

Strong Economics for Community Practices

With the right payer contracts, community cell therapy programs can be economically attractive—especially compared to losing patients entirely to AMCs.

Why Community Delivery Wins

Commercial Payer Opportunity

Episode-based contracts with commercial payers increasingly support community delivery

Reduced Overhead

Our turnkey model minimizes capital investment and fixed costs

Patient Retention

Keep patients in your practice rather than losing them to AMCs

Therapies We Can Help You Deliver

Our platform supports the full range of advanced and emerging therapies, with protocols tailored for community oncology settings.

CAR-T

Yescarta, Kymriah, Breyanzi, Tecartus, Abecma, Carvykti and emerging products

Bispecific Antibodies

Tecvayli, Talvey, Elrexfio, Lunsumio, Columvi, Epkinly and step-up dosing protocols

Expanding Indications

DLBCL, MCL, FL, Multiple Myeloma, ALL, and expanding

Growing Pipeline

New approvals expanding community-appropriate indications

Our Team of Experienced Nurses Helps You Scale with Ease

With deep experience in ED and ICU environments, our in-house team of RNs specialize in remote identification and management of adverse events following advanced therapy administration.

24/7

Support provides continuous coverage and escalation

50

Licensure maintained across all 50 states

2.3

Minute median alarm response time

29%

Of patients with a clinical alarm managed at home

What Patients and Caregivers Say

What Makes a Current Health Partnership Different?

Catch toxicities with confidence.

Our platform has been shown to detect signs of CRS 7 hours earlier than standard of care. Integrated ICANS assessments

Support caregivers and reduce uncertainty.

Continuous monitoring and nurse support help families feel connected and informed.

Standardize care and publish insights.

Ensure consistency as you scale outpatient care models. We'll also help you measure and publish program insights.

Improve workload without sacrificing vigilance.

Offload ICANS assessments, first-line monitoring, triage, and escalation to our 24/7 nurse team.

Ready to Bring Cell Therapy to Your Community?

Talk to our team

Get started